Karabay, A. Z. Et Al. 2024. Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages. TOXICOLOGY IN VITRO , vol.95 .

Karabay, A. Z., Ozkan, T., Koc, A., Hekmatshoar, Y., Gurkan-Alp, A. S., & Sunguroglu, A., (2024). Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages. TOXICOLOGY IN VITRO , vol.95.

Karabay, ARZU Et Al. "Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages," TOXICOLOGY IN VITRO , vol.95, 2024

Karabay, ARZU Z. Et Al. "Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages." TOXICOLOGY IN VITRO , vol.95, 2024

Karabay, A. Z. Et Al. (2024) . "Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages." TOXICOLOGY IN VITRO , vol.95.

@article{article, author={ARZU ZEYNEP KARABAY Et Al. }, title={Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages}, journal={TOXICOLOGY IN VITRO}, year=2024}